Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

INTEGRATED PROTEINS LTD. - 519606 - Financial Results For The Quarter Ended 31St December, 2022 Along With The Limited Review Report For The Same Period.

 Pursuant to the provisions of Regulation 30 (read with Part A of Schedule III) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), we hereby report the outcome of the meeting of the Board of Directors held today, i.e. Monday, 6th February, 2023, inter-alia, considered and approved the unaudited financial results for the quarter ended 6th February 2023 together with the Limited Review Report by the Auditors.
06-02-2023
Bigul

INTEGRATED PROTEINS LTD. - 519606 - Board Meeting Outcome for Outcome Of Board Meeting For The Meeting Held On 6Th February, 2023 For Considering The Unaudited Financial Results For The Quarter Ended 31St December, 2022

 Pursuant to the provisions of Regulation 30 (read with Part A of Schedule III) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), we hereby report the outcome of the meeting of the Board of Directors held today, i.e. Monday, 6th February, 2023, inter-alia, considered and approved the following the unaudited financial results for the quarter ended 31st December, 2022 alongwith the limited review report.
06-02-2023
Bigul

INTEGRATED PROTEINS LTD. - 519606 - Board Meeting Intimation for Considering And Approving The Unaudited Financial Results For The Quarter Ended 31St December, 2022

 INTEGRATED PROTEINS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2023 ,inter alia, to consider and approve considering and approving the unaudited financial results for the quarter ended 31st December, 2022
30-01-2023
Bigul

INTEGRATED PROTEINS LTD. - 519606 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 PFA the certificate under Regulation 74(5) of SEBI(DP) Regulations, 2019 for the quarter ended December 2022. Thank you
15-01-2023
Bigul

INTEGRATED PROTEINS LTD. - 519606 - Board Meeting Outcome for Revised Outcome For The Board Meeting Held On 10Th November, 2022

 Revised outcome This is with reference to the Corporate Announcement submitted by Company dated 10-Nov-2022 . The Revised Outcome is hereby filed by complying with Regulation 30 and SEBI Circular no. CIR/CFD/CMD/4/2015 dated September 09, 2015, thus removing discrepancy as stated.
12-11-2022
Bigul

INTEGRATED PROTEINS LTD. - 519606 - Board Meeting Outcome for Revised Outcome Of The Unaudited Financial Results For The Quarter And Half Year Ended 30Th September, 2022

 Revised outcome is hereby submitted with no change in financial results . Rectifying the discrepancy in the outcome of Board Meeting by attaching the Limited Review Report for the said period which was earlier not attached.
11-11-2022
Bigul

INTEGRATED PROTEINS LTD. - 519606 - Board Meeting Outcome for Revised Outcome Of The Unaudited Financial Results For The Quarter And Half Year Ended 30Th September, 2022

 Revised outcome is hereby submitted with no change in financial results . Rectifying the discrepancy in the outcome of Board Meeting by attaching the Limited Review Report for the said period which was earlier not attached.
11-11-2022
Bigul

INTEGRATED PROTEINS LTD. - 519606 - Unaudited Financial Results For The Quarter And Year Ended 30Th September, 2022

 Unaudited Financial Results and the Limited Review Report for the quarter and year ended 30th September, 2022
10-11-2022
Bigul

INTEGRATED PROTEINS LTD. - 519606 - Board Meeting Outcome for Outcome Of BM

 The Board at its BM held today has interalia considered and approved the financial results for the quarter and year ened 30th September, 2022
10-11-2022
Bigul

INTEGRATED PROTEINS LTD. - 519606 - Board Meeting Intimation for Considering Unaudited Financial Results For The Quarter And Half Year Ended On 30Th September, 2022

 INTEGRATED PROTEINS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2022 ,inter alia, to consider and approve unaudited financial results for the quarter and half year ended on 30th September, 2022
03-11-2022
Next Page
Close

Let's Open Free Demat Account